Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Enters LOI for Exclusive Option on LAG-3 Inhibitor Program
Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Builds Foundation for Biomarker-Driven Cancer Therapy
Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Combines Targeted Cancer Therapy, Nanotechnology and AI
Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Closes C$5 Million Private Placement to Advance Oncology Programs
Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF): Combining Three Emerging Frontiers in Cancer Drug Development
Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Advances Precision Oncology as Biomarker-Driven Cancer Gains Momentum
Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Completes Analytical Reference Standard Program for ONC010
Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Announces Term Sheet for C$5 Million Private Placement
Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Advances ONC010 Manufacturing Development With Nanosoft
Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Engages Nanosoft to Advance ONC010 Development Program
Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Advances ONC010 Program With Successful 300-Gram API Scale-Up Batch